501 results on '"Wu, Shang Ju"'
Search Results
2. Complete response to front-line therapies is associated with long-term survival in HIV-related lymphomas in Taiwan
3. Clinical manifestations and risk factors for COVID-19 and its severity in patients with hematological malignancies
4. Chinese expert consensus on Bruton tyrosine kinase inhibitors in the treatment of B-cell malignancies
5. Impact of proximity of left atrium to descending aorta on left inferior pulmonary vein triggers or drivers of atrial fibrillation: A risk score model
6. Levosimendan attenuates electrical alternans and prevents ventricular arrhythmia during therapeutic hypothermia in isolated rabbit hearts
7. Functional association of NR4A3 downregulation with impaired differentiation in myeloid leukemogenesis
8. Glofitamab monotherapy retreatment in patients with heavily pre-treated relapsed or refractory (R/R) non-Hodgkin lymphoma (NHL): Results from a phase I/II study.
9. Pevonedistat in East Asian patients with acute myeloid leukemia or myelodysplastic syndromes: a phase 1/1b study to evaluate safety, pharmacokinetics and activity as a single agent and in combination with azacitidine
10. Sudden cardiac death in heart failure with preserved ejection fraction: an updated review
11. Bone marrow plasma level of decorin may be associated with improved treatment outcomes in a subset of multiple myeloma patients
12. Updated quality of life data from the phase 3b VENICE II trial: patients with relapsed or refractory chronic lymphocytic leukemia receiving venetoclax monotherapy.
13. Application of Sample Entropy to Analyze Consciousness in CLIS Patients
14. Polatuzumab vedotin–based salvage immunochemotherapy as third-line or beyond treatment for patients with diffuse large B-cell lymphoma: a real-world experience
15. Distinct clinico-biological features in AML patients with low allelic ratio FLT3-ITD: role of allogeneic stem cell transplantation in first remission
16. Signal-averaged electrocardiography as a noninvasive tool for evaluating the ventricular substrate in patients with nonischemic cardiomyopathy: reassessment of an old tool
17. Coexistent diffuse large B-cell lymphoma and disseminated Mycobacterium avium complex infection in a person with AIDS
18. Measurable residual disease in chronic lymphocytic leukemia: expert review and consensus recommendations
19. Glofitamab as a salvage treatment for B‐cell lymphomas in the real world: A multicenter study in Taiwan.
20. Catheter ablation in patients with atrial fibrillation and dilated cardiomyopathy
21. Improved outcomes of localized diffuse large B‐cell lymphoma at the Waldeyer ring in comparison to the sinonasal area in the rituximab era
22. Comparison of Long-Term Clinical Outcomes Between Segmental and Circumferential Pulmonary Vein Isolation in Patients Undergoing Repeat Atrial Fibrillation Ablation
23. Clinical significance of substrate characteristics and ablation outcomes in patients with atrial fibrillation and significant functional mitral regurgitation
24. POSTER: ABCL-478 Glofitamab in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma and ≥2 Prior Therapies: Results From a Pivotal Phase II Expansion Study
25. ABCL-478 Glofitamab in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma and ≥2 Prior Therapies: Results From a Pivotal Phase II Expansion Study
26. Application of Sample Entropy to Analyze Consciousness in CLIS Patients
27. Successful treatment of nasal-type extra-nodal natural killer/T cell lymphoma with simultaneous involvement of the thyroid, liver, and pancreas
28. Immunotherapeutic potential of blinatumomab-secreting γ9δ2 T Cells
29. PO-02-159 ABLATION OF ATRIAL FIBRILLATION AND DEMENTIA RISK REDUCTION DURING LONG-TERM FOLLOW-UP: A NATIONWIDE POPULATION-BASED STUDY
30. PO-02-101 CATHETER ABLATION IN ASIAN PATIENTS WITH ATRIAL FIBRILLATION AND DILATED CARDIOMYOPATHY: ELECTROPHYSIOLOGICAL CHARACTERISTICS OF RECURRENCE AND LONG-TERM CLINICAL OUTCOMES
31. PO-04-169 DELAYED EFFECT OF CATHETER ABLATION FOR INTRAMURAL OUTFLOW TRACT VENTRICULAR ARRHYTHMIAS
32. PO-02-199 A NOVEL FINDING: SERUM MICRORNA-122 CORRELATES WITH LEFT ATRIAL SUBSTRATE IN PATIENTS WITH ATRIAL FIBRILLATION
33. PO-05-073 CHARACTERISTICS OF BIPOLAR AND UNIPOLAR ELECTROGRAMS AT SUCCESSFUL ABLATION TARGETS FOR VENTRICULAR ARRHYTHMIA ORIGINATING FROM THE VICINITY OF LEFT VENTRICULAR SUMMIT
34. PO-01-228 CLINICAL SIGNIFICANCE OF STRUCTURAL REMODELING CONCERNING SUBSTRATE CHARACTERISTICS AND ABLATION OUTCOMES IN PATIENTS WITH ATRIAL FIBRILLATION AND MITRAL REGURGITATION
35. PO-05-021 HYPERTROPHIC CARDIOMYOPATHY INCREASES THE RISKS OF BRADYARRHYTHMIA AND PACEMAKER IMPLANTATION
36. Data from Phosphoproteomics Reveals the Role of Constitutive KAP1 Phosphorylation by B-cell Receptor Signaling in Chronic Lymphocytic Leukemia
37. Supplementary Data from Phosphoproteomics Reveals the Role of Constitutive KAP1 Phosphorylation by B-cell Receptor Signaling in Chronic Lymphocytic Leukemia
38. Supplementary Table 1 from Nucleophosmin Mutations in De novo Acute Myeloid Leukemia: The Age-Dependent Incidences and the Stability during Disease Evolution
39. Long non-coding RNA HOXB-AS3 promotes myeloid cell proliferation and its higher expression is an adverse prognostic marker in patients with acute myeloid leukemia and myelodysplastic syndrome
40. Coexistent disseminated Kaposi's sarcoma and disseminated Mycobacterium avium complex infection in a patient with AIDS
41. Concerted mass spectrometry-based glycomic approach for precision mapping of sulfo sialylated N-glycans on human peripheral blood mononuclear cells and lymphocytes
42. Glofitamab for Relapsed or Refractory Diffuse Large B-Cell Lymphoma
43. Cerebrospinal fluid soluble programmed death‐ligand 1 is a useful prognostic biomarker in primary central nervous system lymphoma
44. Inotuzumab ozogamicin as a single agent to treat T315I-mutated chronic myeloid leukemia with acute blastic change to CD22+ acute lymphocytic leukemia
45. Inotuzumab ozogamicin as a single agent to treat T315I-mutated chronic myeloid leukemia with acute blastic change to CD22+ acute lymphocytic leukemia
46. Distinct Immunogenetic Profiles of Chronic Lymphocytic Leukemia in Asia: A Taiwan Cooperative Oncology Group Registry Study
47. Cost-Effectiveness Analysis of Frontline Treatment with Polatuzumab Vedotin in Diffuse Large B-Cell Lymphoma
48. Specific refraction-index increments of oxygenated hemoglobin from thalassemia-minor patients are not significantly different than those from healthy individuals
49. GATA2 zinc finger 1 mutations are associated with distinct clinico-biological features and outcomes different from GATA2 zinc finger 2 mutations in adult acute myeloid leukemia
50. Design and Evaluation of a Real Time Physiological Signals Acquisition System Implemented in Multi-Operating Rooms for Anesthesia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.